Depression

Depression (clinically, major depressive disorder) is a common but serious mood disorder that causes a persistent low mood or loss of interest in activities, lasting at least two weeks and interfering with how a person sleeps, eats, works, and feels. It is a treatable medical condition — not a personal weakness or a passing bad mood — and most people improve substantially with the right combination of therapy, lifestyle changes, and, when needed, medication.

What is depression?

Depression is a mental health condition defined by a depressed mood or a loss of pleasure and interest (called *anhedonia*) that is present most of the day, nearly every day, for at least two weeks, alongside a cluster of physical and cognitive symptoms. It is distinct from ordinary sadness or grief: depression is more pervasive, more persistent, and disproportionate in its effect on daily functioning.

The most common diagnosis is major depressive disorder (MDD), coded as F32 (single episode) or F33 (recurrent) in ICD-10. But depression is an umbrella that includes several related conditions:

• Persistent depressive disorder (dysthymia) — a chronic, lower-grade depression lasting two years or more.
• Perinatal (postpartum) depression — major depression occurring during pregnancy or in the weeks to months after childbirth.
• Seasonal affective disorder (SAD) — recurrent depression with a seasonal pattern, typically in fall and winter.
• Premenstrual dysphoric disorder (PMDD) — severe mood symptoms tied to the menstrual cycle.
• Bipolar depression — depressive episodes that occur in people who also have manic or hypomanic episodes. This distinction matters because the treatment differs (NIH).

Depression is genuinely common. According to the National Institute of Mental Health, drawing on the 2021 National Survey on Drug Use and Health, an estimated 8.3% of U.S. adults — about 21.0 million people — had at least one major depressive episode that year, with the highest rate (18.6%) among adults aged 18 to 25 (NIMH). Among adolescents aged 12 to 17, the past-year rate was 20.1% (NIMH). Women are more likely than men to have a major depressive episode in a given year (10.3% vs. 6.2%, NIMH).

What causes depression and who's at risk?

There is no single cause. Depression results from an interaction of biological, psychological, and environmental factors. The older "chemical imbalance" explanation — the idea that depression is simply too little serotonin — is now understood to be an oversimplification; current research points to a more complex picture involving genetics, brain circuitry, stress hormones, inflammation, and neuroplasticity (StatPearls).

Well-established risk factors include:

• Family history and genetics. Having a first-degree relative with depression increases risk substantially. A meta-analysis of twin studies puts heritability at about 37%, meaning genes load the gun but environment often pulls the trigger.
• Personal history. A previous depressive episode is one of the strongest predictors of a future one.
• Chronic stress and trauma. Childhood adversity, abuse, neglect, or ongoing life stress (financial strain, caregiving, isolation) raise risk.
• Medical illness. Depression is more common in people with chronic conditions such as diabetes, heart disease, stroke, cancer, chronic pain, Parkinson's disease, and thyroid disorders. The relationship runs both ways.
• Substance use. Alcohol and other substances can both trigger and worsen depression.
• Certain medications. Some drugs (for example, certain corticosteroids or interferon) list depression as a possible effect.
• Hormonal transitions. Pregnancy, the postpartum period, and perimenopause are higher-risk windows.
• Sleep disruption. Chronic insomnia is both a symptom and an independent risk factor.

Importantly, depression also occurs in people with no identifiable trigger and no obvious "reason." That does not make it less real or less treatable.

What are the symptoms of depression?

Depression affects mood, body, and thinking. The core symptom is either a low mood or a loss of interest, but it rarely travels alone. Common features include:

• Persistent sadness, emptiness, or hopelessness
• Loss of interest or pleasure in activities once enjoyed (anhedonia)
• Significant changes in appetite or weight (up or down)
• Sleeping too little or too much
• Fatigue or low energy nearly every day
• Slowed movements or speech, or restlessness, noticeable to others
• Feelings of worthlessness or excessive, inappropriate guilt
• Difficulty concentrating, remembering, or making decisions
• Recurrent thoughts of death or suicide, or a suicide attempt

Symptoms can look different across people. Some experience depression mainly as physical complaints — unexplained aches, digestive problems, or exhaustion. In men, depression may present more as irritability, anger, or reckless behavior. In older adults, memory problems and physical symptoms can mask the mood component. In children and teens, irritability is often more prominent than sadness.

How is depression diagnosed?

There is no blood test or brain scan that diagnoses depression. Diagnosis is clinical, based on a structured interview and standardized criteria, usually with lab work to rule out other causes.

Diagnostic criteria

Clinicians use the DSM-5-TR criteria for major depressive disorder. A diagnosis requires five or more of nine specified symptoms present during the same two-week period, representing a change from previous functioning. Critically, at least one of the five must be either (1) depressed mood or (2) loss of interest or pleasure. The symptoms must cause clinically significant distress or impairment and must not be better explained by a substance, a medical condition, or another disorder. A history of a manic or hypomanic episode points toward bipolar disorder rather than MDD and must be ruled out (StatPearls).

Screening tools and thresholds

The most widely used screening instrument is the PHQ-9 (Patient Health Questionnaire-9), a nine-item self-report scale mapping directly onto the DSM-5 criteria. It scores from 0 to 27:

• 0–4: minimal or no depression
• 5–9: mild
• 10–14: moderate
• 15–19: moderately severe
• 20–27: severe

A score of 10 or higher is the commonly used threshold suggesting probable major depression and warranting further evaluation. A shorter two-item version, the PHQ-2, is often used as a first-pass screen. The U.S. Preventive Services Task Force (USPSTF) recommends screening for depression in the adult population, including pregnant and postpartum people and older adults (USPSTF, 2023, grade B).

Ruling out other causes

Because thyroid disease, anemia, vitamin B12 deficiency, and other conditions can mimic depression, clinicians often order labs such as thyroid function tests and a complete blood count. They will also review medications, substance use, and sleep.

How is depression treated?

Depression is highly treatable, and treatment is matched to severity. Mild depression may respond to lifestyle changes and psychotherapy alone; moderate to severe depression usually warrants medication, therapy, or both. The general principle is to start with the least invasive effective option and escalate as needed.

Lifestyle and first-line non-drug steps

For mild-to-moderate depression, the following have genuine evidence behind them and are recommended as a foundation (often alongside other treatment):

• Regular physical activity. Aerobic exercise has a meaningful antidepressant effect and is one of the best-supported lifestyle interventions.
• Sleep regulation. Treating insomnia directly often improves mood.
• Structured routine and behavioral activation — deliberately re-engaging with rewarding activities even when motivation is absent.
• Reducing alcohol and other depressants.
• Social connection and reducing isolation.

Psychotherapy is first-line and as effective as medication for many people with mild-to-moderate depression. The best-supported forms include cognitive behavioral therapy (CBT), interpersonal therapy (IPT), and behavioral activation.

Over-the-counter and complementary options

Evidence here is limited and OTC products are not substitutes for treatment of moderate-to-severe depression. Some agents have modest supporting data — for example, *St. John's wort* has shown benefit for mild depression in some studies but carries serious drug interactions (including with antidepressants, birth control, and blood thinners) and should not be combined with prescription antidepressants. Omega-3 fatty acids and vitamin D have mixed evidence. Bright-light therapy is well supported specifically for seasonal affective disorder. Anyone considering supplements should review them with a clinician or pharmacist first.

Prescription medication

When medication is indicated, guidelines from the American Psychiatric Association and others identify several first-line antidepressant classes. No single class is clearly superior overall; selection is individualized based on side-effect profile, other symptoms, and patient preference:

• SSRIs (selective serotonin reuptake inhibitors) — for example sertraline, escitalopram, fluoxetine, citalopram. Usually the default first choice due to a favorable safety and tolerability profile.
• SNRIs (serotonin-norepinephrine reuptake inhibitors) — for example venlafaxine, duloxetine. Often used when pain coexists.
• Atypical / other second-generation agents — bupropion (helpful when fatigue or sexual side effects are concerns, and it does not typically cause weight gain) and mirtazapine (useful when insomnia and poor appetite are prominent).
• Vortioxetine and other newer agents are also used.

Older classes — tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs) — remain effective but are generally not first-line because of side effects, overdose risk, and dietary or drug interactions. They are reserved for cases that don't respond to safer options.

Two practical points patients should know: antidepressants typically take four to eight weeks to show meaningful benefit, and they should not be stopped abruptly because of discontinuation symptoms — tapering under medical supervision is important. Regulators also require a warning that antidepressants may increase suicidal thoughts in people under 25, especially early in treatment, which is one reason close follow-up matters in the first weeks.

Treatment-resistant and severe depression

When two adequate medication trials don't work — referred to as treatment-resistant depression — additional options exist:

• Esketamine (an FDA-approved intranasal medication, given only in a certified, monitored clinical setting under a Risk Evaluation and Mitigation Strategy), which can work rapidly. It is approved for treatment-resistant depression and for depressive symptoms in adults with major depressive disorder who have acute suicidal ideation or behavior.
• Transcranial magnetic stimulation (TMS), a noninvasive, FDA-cleared brain-stimulation therapy.
• Electroconvulsive therapy (ECT), which remains among the most effective treatments for severe or life-threatening depression, with response rates often exceeding 70% in clinical reports, and is delivered under anesthesia.

Can depression be prevented or managed long-term?

Depression cannot always be prevented, but risk and recurrence can be reduced. Because a prior episode strongly predicts future ones, long-term management focuses on *relapse prevention*: maintaining treatment for an adequate duration, recognizing early warning signs, protecting sleep, staying physically active, limiting alcohol, and keeping social and professional supports in place.

For people who have had a single episode, guidelines generally recommend continuing antidepressant treatment for several months after symptoms resolve to reduce relapse risk. For those with recurrent episodes, longer-term or maintenance treatment is often advised. Psychotherapy — particularly CBT and mindfulness-based cognitive therapy — has evidence for reducing relapse even after medication is stopped. Treating coexisting conditions (anxiety, chronic pain, substance use, thyroid disease) also improves outcomes.

When should you see a doctor?

See a healthcare professional if low mood or loss of interest lasts two weeks or longer, or if symptoms interfere with work, relationships, or daily functioning. Earlier evaluation is better — depression tends to respond better the sooner it is treated.

Seek emergency help immediately for any of these red flags:

• Thoughts of suicide, self-harm, or feeling that others would be better off without you
• A specific plan or intent to harm yourself
• Thoughts of harming someone else
• Inability to care for yourself (not eating, not getting out of bed for days)
• Symptoms of psychosis (hearing or seeing things others don't, or fixed false beliefs)

In the United States, anyone in crisis can call or text 988 to reach the Suicide and Crisis Lifeline, available 24/7, or go to the nearest emergency department. These warning signs are medical emergencies, not moments to "wait and see."

What is the outlook for depression?

The prognosis for depression is generally good, and this is the most important message: most people who receive adequate treatment improve, and many recover fully. With appropriate therapy and/or medication, a large proportion of people achieve significant symptom reduction or full remission, though it sometimes takes more than one treatment adjustment to find the right fit.

Depression can be episodic (one or a few discrete episodes) or recurrent, and untreated episodes tend to last longer and recur more often. The realistic outlook: depression is a chronic-relapsing condition for some and a one-time event for others, but in both cases it is manageable. Staying engaged with treatment, building relapse-prevention habits, and seeking help early during warning signs are the factors most associated with lasting recovery.

Frequently asked questions

Is depression a chemical imbalance? Not exactly. The simple "low serotonin" model is now considered outdated. Depression involves a combination of genetics, brain circuit function, stress and hormonal systems, inflammation, life events, and psychology. Antidepressants do affect brain chemistry, but that doesn't mean depression is caused by a single chemical deficiency.

How long do antidepressants take to work? Most people don't feel the full effect for four to eight weeks. Some early changes (sleep, appetite, energy) may come first, with mood improving later. If there's no meaningful benefit after an adequate trial at an adequate dose, clinicians often adjust the dose or switch agents. Don't stop abruptly — taper under medical guidance.

Can depression go away on its own? Some milder episodes do resolve over time, but this is unpredictable, and waiting carries risk — untreated depression can last longer, deepen, and recur. Treatment shortens episodes and lowers relapse risk, so professional evaluation is worthwhile rather than simply waiting it out.

What's the difference between depression and just feeling sad? Sadness is a normal, usually temporary response to a specific event and doesn't typically derail your functioning. Clinical depression is more persistent (two weeks or more), more pervasive, and impairs daily life — affecting sleep, appetite, concentration, energy, and self-worth — often without a clear external trigger.

Is depression genetic? Genetics contribute meaningfully — heritability is estimated at about 37%, and a family history raises risk — but genes are not destiny. Many people with a family history never develop depression, and many with depression have no family history. Environment, stress, and life circumstances play a large role.

---

*This page is for general education and is not medical advice. Depression is a medical condition that should be evaluated and treated by a qualified clinician. If you are in crisis or thinking about suicide, call or text 988 (U.S.) or go to your nearest emergency department.*